Forced Degradation studies of CNS Drugs and Identification of Possible Degradants by Chromatographic Techniques

dc.contributor.guideRajasekaran A
dc.coverage.spatial
dc.creator.researcherTamilselvi N
dc.date.accessioned2024-09-19T06:54:50Z
dc.date.available2024-09-19T06:54:50Z
dc.date.awarded2018
dc.date.completed2016
dc.date.registered2012
dc.description.abstractForced degradation studies under rigorous conditions should be conceded on drug to find out the inherent strength character also degradation pathway to maintain the correctness of the planned analytical procedures. Further, the identification of degradants in pharmaceuticals is critically important for reasons of both product efficacy and patient safety. There are no reports for the identification of degradants by chromatographic techniques for the recent CNS drugs viz Ezogabine and Zolpidem tartrate. Complete LC plus LCMS method of degradation behavior on these CNS drugs under different ICH prescribed stress conditions have also be deficient. Ezogabine or retigabine (RTG) chemically called as N-(2-amino-4-(4-fluorobenzylamino) phenyl) carbamic acid ethyl ester. The drug is a new anti-epileptic drug and the drug is not official in IP, BP and USP. The drug is a colorless and freely soluble in polar solvents. Zolpidem tartrate (ZOL), chemically called as N, N-dimethyl-2-[6-methyl-2-(4-methylphenyl) imidazo [1, 2-a] pyridin-3-yl] acetamide L (+) tartrate. The drug is used as hypnotic. The drug is a colorless crystalline powder and sparingly soluble in alcohol plus water. Zolpidem tartrate is official in IP20 (2014) and USP20 (2011). IMPACT OF THE STUDY: Developed and validated a stability indicating RP-HPLC method for the determination of selected CNS drugs like Ezogabine in bulk form and Zolpidem tartrate present in tablet dosage form. To assess stability profile of these drug /drug products during manufacturing, processing, storage conditions and safety. Forced degradation studies were carried out for the selected CNS drugs like Ezogabine and Zolpidem tartrate. Degradation product of ezogabine and zolpidem tartrate were separated by preparative HPLC method and identified by IR, NMR and mass spectral data. Degradation product of ezogabine and zolpidem tartrate were used for the determination of mutagenicity and found non mutagenic by Ames test. Full mass accountability of the degradation products was obtained.
dc.description.note
dc.format.accompanyingmaterialNone
dc.format.dimensions
dc.format.extent263
dc.identifier.urihttp://hdl.handle.net/10603/590112
dc.languageEnglish
dc.publisher.institutionDepartment of Pharmacy
dc.publisher.placeChennai
dc.publisher.universityThe Tamil Nadu Dr. M.G.R. Medical University
dc.relation
dc.rightsuniversity
dc.source.universityUniversity
dc.subject.keywordChromatographic Techniques
dc.subject.keywordCNS Drugs
dc.subject.keywordEzogabine
dc.subject.keywordForced Degradation studies
dc.subject.keywordIdentification
dc.subject.keywordPossible Degradants
dc.subject.keywordZolpidem tartrate
dc.titleForced Degradation studies of CNS Drugs and Identification of Possible Degradants by Chromatographic Techniques
dc.title.alternative
dc.type.degreePh.D.

Files

Original bundle

Now showing 1 - 5 of 12
Loading...
Thumbnail Image
Name:
01_title.pdf
Size:
131.03 KB
Format:
Adobe Portable Document Format
Description:
Attached File
Loading...
Thumbnail Image
Name:
02_prelim pages.pdf
Size:
10.19 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
03_content.pdf
Size:
1.77 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
05_chapter 1.pdf
Size:
2.9 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
06_chapter 2.pdf
Size:
1.26 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: